These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17682138)

  • 41. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry.
    Kainz C; Gitsch G; Lee A; Danihel L; Breitenecker G
    Anticancer Res; 1993; 13(1):73-4. PubMed ID: 7682802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ISET device: a useful tool to answer some questions about the biologic behavior of melanocytic nevus cells.
    Descamps V; Basset-Seguin N; Soufir N
    Arch Dermatol; 2010 Oct; 146(10):1156-7. PubMed ID: 20956651
    [No Abstract]   [Full Text] [Related]  

  • 43. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proceedings: Primary breast cancer: identification of poor prognosis.
    Blamey RW; Elston CR; Davies CJ; Preston B
    Br J Surg; 1976 Feb; 63(2):158. PubMed ID: 1252753
    [No Abstract]   [Full Text] [Related]  

  • 45. Inclusions of benign nevus cells in the capsule of axillary lymph nodes in three cases of breast cancer.
    Gădăleanu V; Mureşan R
    Morphol Embryol (Bucur); 1984; 30(2):137-9. PubMed ID: 6330543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnosis and clinical significance of disseminated tumor cells in bone marrow].
    Braun S; Pantel K
    Dtsch Med Wochenschr; 2000 Oct; 125(41):1237-9. PubMed ID: 11076263
    [No Abstract]   [Full Text] [Related]  

  • 47. Breast cancer symposium. Points in the practical management of breast cancer. How and why does one "stage" a patient?
    Burn JI
    Br J Surg; 1969 Oct; 56(10):787-9. PubMed ID: 5347586
    [No Abstract]   [Full Text] [Related]  

  • 48. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study.
    Mikhitarian K; Martin RH; Mitas M; Mauldin PD; Palesch Y; Metcalf JS; Cole DJ; Gillanders WE;
    Surgery; 2005 Sep; 138(3):474-81. PubMed ID: 16213901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Breast cancer and lymph node metastasis: relation of lymph node dimensions and metastasis].
    Cappello F; Barresi E; Martorana A
    Pathologica; 2000 Feb; 92(1):5-8. PubMed ID: 10842993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cancer cells in peripheral lymph and blood and their effect on the morbidity of patients with breast cancer].
    Putyrskiĭ LA
    Ross Med Zh; 1992; (4):39-42. PubMed ID: 1521020
    [No Abstract]   [Full Text] [Related]  

  • 52. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].
    Degnim AC; Zakaria S; Boughey JC; Sookhan N; Reynolds C; Donohue JH; Farley DR; Grant CS; Hoskin T
    Ann Surg Oncol; 2010 Oct; 17(10):2685-9. PubMed ID: 20390457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carcinoma of the breast and of the ovary as a model for the application of monoclonal antibodies to diagnostic pathology.
    Rilke F; Colnaghi MI; Ménard S; Tagliabue E; Mariani-Costantini R; Della Torre G
    Monogr Pathol; 1986; (27):206-24. PubMed ID: 3020396
    [No Abstract]   [Full Text] [Related]  

  • 54. Identification of micrometastasis of breast carcinomas by presence of basement membrane collagen.
    Liotta LA; Foidart JM; Robey PG; Martin GR; Gullino PM
    Lancet; 1979 Jul; 2(8134):146-7. PubMed ID: 88575
    [No Abstract]   [Full Text] [Related]  

  • 55. Breast cancer micrometastases in lymph nodes and bone marrow are prognostically important.
    Neville AM
    Ann Oncol; 1991 Jan; 2(1):13-4. PubMed ID: 2009231
    [No Abstract]   [Full Text] [Related]  

  • 56. [Galectin-9 as a possible suppressor for metastasis of breast cancer].
    Yamauchi A
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():448-53. PubMed ID: 23350440
    [No Abstract]   [Full Text] [Related]  

  • 57. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Kuo JF; Lin WL; Han CP
    Cancer; 2011 Jun; 117(11):2578; author reply 2579. PubMed ID: 21437894
    [No Abstract]   [Full Text] [Related]  

  • 58. Monoclonal antibodies as probes of human breast disorders.
    Neville AM; Foster C; Redding H; Coombes RC
    Ann N Y Acad Sci; 1983; 417():251-61. PubMed ID: 6584081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Micrometastasis detection and treatment with monoclonal antibodies.
    Pantel K; Riethmüller G
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():1-18. PubMed ID: 8814999
    [No Abstract]   [Full Text] [Related]  

  • 60. [Immunologic studies of bone marrow aspirations in breast cancer patients at the time of primary therapy].
    Forell-Engelken G; Eiermann W; Untch M
    Arch Gynecol Obstet; 1989; 245(1-4):722-4. PubMed ID: 2802759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.